Product Recalls in Ohio

Product recalls affecting Ohio — including food, drugs, consumer products, medical devices, and vehicles distributed to Ohio. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,806 recalls have been distributed to Ohio in the last 12 months.

55,415 total recalls
2,806 in last 12 months

Showing 21012120 of 13,469 recalls

DrugMarch 14, 2023· Ascend Laboratories, LLC

Recalled Item: Dabigatran Etexilate Capsules Recalled by Ascend Laboratories, LLC Due to...

The Issue: CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Camber Pharmaceuticals Inc.

Recalled Item: Atovaquone Oral Suspension USP Recalled by Camber Pharmaceuticals Inc. Due...

The Issue: Microbial Contamination of Non-Sterile Product: Objectionable organism,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Simvastatin Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Glimepiride Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Simvastatin Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Ropinirole Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Glimepiride Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Glimepiride Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Ropinirole Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Simvastatin Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Finasteride Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Montelukast Sodium Tablets Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Simvastatin Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 9, 2023· Boehringer Ingelheim Pharmaceuticals, Inc.

Recalled Item: JARDIANCE (Empagliflozin) Recalled by Boehringer Ingelheim Pharmaceuticals,...

The Issue: Labeling: Label Mix-up

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 9, 2023· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Dofetilide Capsules Recalled by SUN PHARMACEUTICAL INDUSTRIES INC Due to...

The Issue: Failed Content Uniformity Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 8, 2023· Pfizer Inc.

Recalled Item: MEKTOVI (binimetinib) tablets Recalled by Pfizer Inc. Due to Labeling:...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date: The carton and bottle...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund